ARLINGTON, Va. – National Association of Chain Drug Stores (NACDS) president and CEO Steven Anderson issued the following statement Tuesday:
“Words like ‘continuing resolution,’ ‘budget reconciliation,’ and ‘standalone bill’ are the words of Washington, DC. While all of these legislative vehicles are sorted out, one fact remains: pharmacy benefit manager (PBM) reform remains a long overdue need and the costs of inaction continue to ravage Americans, their pharmacies, and their communities.
“Every day, Americans are living with the acceleration of prescription drug price inflation and the closing of trusted and convenient pharmacies.At the hands of the PBM middlemen, nearly four pharmacies are closing each day – at an increasing rate. Americans have missed out on hundreds of millions of dollars of savings just since the last Congress ended. The costs of inaction on PBM reform are massive and they are growing, all while the PBMs redouble their revenue.
"Meanwhile, Congress has reforms ready to go – a sound package that was finalized last December. Americans need this win and it is time to deliver it to them. As Congress and the Administration figure out the legislative roadmap, PBM reform needs to get done without further needless delay.”
More information is available on a new NACDS fact sheet.
NACDS: A legislative vehicle must include PBM reform; inaction is costing Americans
Nearly four pharmacies are closing every day; Americans are missing out on hundreds of millions in savings just since the last Congress' end.
Related
RxConnexion named Preferred Vendor by RxPOA to empower independent pharmacies across the country
This strategic partnership enables RxPOA members to access RxConnexion’s full suite of services at preferred pricing—designed specifically to help independent pharmacies grow, increase profitability, and expand their clinical impact in the communities they serve.
Dr. Cristian Massacesi named executive vice president, chief medical officer and head of development at Bristol Myers Squibb
He will oversee the company’s early-stage and late-stage product development across all therapeutic areas.
NCPA applauds bill to reimburse pharmacists for treating COVID, flu, and other ailments
“This legislation protects patient access, especially for people in rural areas where pharmacists can be the only healthcare provider for many miles,” said NCPA CEO B. Douglas Hoey.
NACDS praises Senate action to ensure seniors on Medicare have access to certain state-approved pharmacist services
Bipartisan bill stands to enhance healthcare delivery for seniors nationwide, especially those in communities where provider shortages persist.
Latest
RxConnexion named Preferred Vendor by RxPOA to empower independent pharmacies across the country
This strategic partnership enables RxPOA members to access RxConnexion’s full suite of services at preferred pricing—designed specifically to help independent pharmacies grow, increase profitability, and expand their clinical impact in the communities they serve.
Nature's Garden by Cibo Vita announces 2025 Consumer and Trade Awards for Probiotic Fruit Snacks and Innovation
The brand's signature offerings have received national and international praise across consumer and trade platforms.
Dr. Cristian Massacesi named executive vice president, chief medical officer and head of development at Bristol Myers Squibb
He will oversee the company’s early-stage and late-stage product development across all therapeutic areas.
NCPA applauds bill to reimburse pharmacists for treating COVID, flu, and other ailments
“This legislation protects patient access, especially for people in rural areas where pharmacists can be the only healthcare provider for many miles,” said NCPA CEO B. Douglas Hoey.